Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection

Journal of Hepatology

Volumn 61, Issue 2, 2014, Pages 210-218

  Byrne, Dana D ^a,b   Newcomb, Craig W ^b   Carbonari, Dena M ^b   Nezamzadeh, Melissa S ^b   Leidl, Kimberly B F ^b   Herlim, Maximilian ^b   Yang, Yu Xiao ^a,b   Hennessy, Sean ^b   Kostman, Jay R ^a   Leonard, Mary B ^b,c   Localio, A Russell ^b   Lo Re, Vincent ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone; Fracture; Hepatitis B

Indexed keywords

ACETYLSALICYLIC ACID; ADEFOVIR; ALPHA INTERFERON; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; EMTRICITABINE; ENTECAVIR; ESTROGEN; GABAPENTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMIVUDINE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PEGINTERFERON ALPHA; PROTON PUMP INHIBITOR; TELBIVUDINE; TENOFOVIR; THIAZIDE DIURETIC AGENT; THYROXINE; VITAMIN D;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BLACK PERSON; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPEAN AMERICAN; FEMALE; HAZARD RATIO; HEPATITIS B; HEPATITIS B VIRUS; HIP FRACTURE; HISPANIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; UNITED STATES; AGED; COMPLICATION; HEPATITIS B, CHRONIC; HIP FRACTURES; RISK;

ADULT; AGED; COHORT STUDIES; FEMALE; HEPATITIS B, CHRONIC; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK;

EID: 84904727761     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.04.001     Document Type: Article

References (48)

1. B. Custer, S.D. Sullivan, T.K. Hazlet, U. Iloeje, D.L. Veenstra, and K.V. Kowdley Global epidemiology of hepatitis B virus J Clin Gastroenterol 38 2004 S158 S168
2. D. Lavanchy Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepat 11 2004 97 107
3. B.J. McMahon Epidemiology and natural history of hepatitis B Semin Liver Dis 25 2005 3 8
4. S. Pungpapong, W.R. Kim, and J.J. Poterucha Natural history of hepatitis B virus infection: an update for clinicians Mayo Clin Proc 82 2007 967 975
5. S. Pungpapong, and W.R. Kim In the eye of the B-holder: natural history of chronic hepatitis B Hepatology 58 2013 6 8
6. J.E. Hay Bone disease in cholestatic liver disease Gastroenterology 108 1995 276 283
7. W.D. Leslie, C.N. Bernstein, and M.S. Leboff AGA technical review on osteoporosis in hepatic disorders Gastroenterology 125 2003 941 966
8. S. Rouillard, and N.E. Lane Hepatic osteodystrophy Hepatology 33 2001 301 307
9. Fung S, Fabri M, Wong F, Heathcote J, Gurel S, Kwan WCP, et al. Reduced bone mineral density derived from dual X-ray absorptiometry (DEXA) assessments in patients with chronic hepatitis B (CHB). In: 46th Annual Meeting of the European Association for the Study of the Liver. Berlin, Germany. March 30-April 3, 2011 [Abstract 2382].
10. U.S. Gill, S. Al-Shamma, K. Burke, V. Ross, R. Marley, and P. Kooner et al. Factors determining bone mineral density loss in chronic hepatitis B patients: Is tenofovir disoproxil fumarate the main culprit? J Hepatol 54 2011 S286
11. R. Olsson, C. Johansson, G. Lindstedt, and D. Mellstrom Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis Scand J Gastroenterol 29 1994 753 756
12. I. Schiefke, A. Fach, M. Wiedmann, A.V. Aretin, E. Schenker, and G. Borte et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection World J Gastroenterol 11 2005 1843 1847
13. V. Lo Re 3rd, G. Guaraldi, M.B. Leonard, A.R. Localio, J. Lin, and G. Orlando et al. Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men AIDS 23 2009 2191 2198
14. S. Lawson-Ayayi, C. Cazanave, A. Kpozehouen, N. Barthe, N. Mehsen, and M. Hessamfar et al. Chronic viral hepatitis is associated with low bone mineral density in HIV-infected patients, ANRS CO 3 Aquitaine Cohort J Acquir Immune Defic Syndr 62 2013 430 435
15. L. Gilbert, X. He, P. Farmer, J. Rubin, H. Drissi, and A.J. van Wijnen et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha J Biol Chem 277 2002 2695 2701
16. J.L. Gonzalez-Calvin, F. Gallego-Rojo, R. Fernandez-Perez, F. Casado-Caballero, E. Ruiz-Escolano, and E.G. Olivares Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis J Clin Endocrinol Metab 89 2004 4325 4330
17. A. Mittalhenkle, D.L. Gillen, and C.O. Stehman-Breen Increased risk of mortality associated with hip fracture in the dialysis population Am J Kidney Dis 44 2004 672 679
18. J.A. Baron, J. Barrett, D. Malenka, E. Fisher, W. Kniffin, and T. Bubolz et al. Racial differences in fracture risk Epidemiology 5 1994 42 47
19. J. Fang, R. Freeman, R. Jeganathan, and M.H. Alderman Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City Ethn Dis 14 2004 280 284
20. C.A. Brauer, M. Coca-Perraillon, D.M. Cutler, and A.B. Rosen Incidence and mortality of hip fractures in the United States JAMA 302 2009 1573 1579
21. N.C. Wright, K.G. Saag, J.R. Curtis, W.K. Smith, M.L. Kilgore, and M.A. Morrisey et al. Recent trends in hip fracture rates by race/ethnicity among older US adults J Bone Miner Res 27 2012 2325 2332
22. S. Hennessy, W.B. Bilker, A. Weber, and B.L. Strom Descriptive analyses of the integrity of a US Medicaid claims database Pharmacoepidemiol Drug Saf 12 2003 103 111
23. Centers for Medicare & Medicaid Services. Medicaid Statistical Information System (MSIS) Tables. http://www.cms.gov/MedicaidDataSourcesGenInfo/ MSIS/list.asp. Accessed December 22, 2013.
24. Centers for Medicare & Medicaid Services. Medicaid Analytic eXtract (MAX) Validation Reports. http://www.cms.gov/MedicaidDataSourcesGenInfo/MVR/ list.asp. Accessed December 22, 2013.
25. Medicare Payment Advisory Commission. Report to the Congress: New Approaches in Medicare; 2004.
26. S. Hennessy, C.E. Leonard, C.M. Palumbo, C. Newcomb, and W.B. Bilker Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid Services (CMS) Med Care 45 2007 1216 1220
27. D.D. Byrne, C.W. Newcomb, D.M. Carbonari, M.S. Nezamzadeh, K.B.F. Leidl, and M. Herlim et al. Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007 Ann Epidemiol 2014 [In Press]. http://dx.doi.org/10.1016/j.annepidem.2014.02.013
28. A.S. Lok, and B.J. McMahon Chronic hepatitis B Hepatology 45 2007 507 539
29. V. Lo Re 3rd, J. Volk, C.W. Newcomb, Y.X. Yang, C.P. Freeman, and S. Hennessy et al. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection Hepatology 56 2012 1688 1698
30. B. Young, C.N. Dao, K. Buchacz, R. Baker, and J.T. Brooks Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006 Clin Infect Dis 52 2011 1061 1068
31. J.A. Womack, J.L. Goulet, C. Gibert, C. Brandt, C.C. Chang, and B. Gulanski et al. Increased risk of fragility fractures among HIV infected compared to uninfected male veterans PLoS One 6 2011 e17217
32. L. Kish Survey sampling 1965 John Wiley & Sons, Inc. New York, NY
33. W.A. Ray, M.R. Griffin, R.L. Fought, and M.L. Adams Identification of fractures from computerized Medicare files J Clin Epidemiol 45 1992 703 714
34. D. Goldberg, J. Lewis, S. Halpern, M. Weiner, and V. Lo Re 3rd Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database Pharmacoepidemiol Drug Saf 21 2012 765 769
35. L.E. Braitman, and P.R. Rosenbaum Rare outcomes, common treatments: analytic strategies using propensity scores Ann Intern Med 137 2002 693 695
36. R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
37. E.A. Stuart Matching methods for causal inference: a review and a look forward Stat Sci 25 2010 1 21
38. D. Collett Modeling survival data in medical research 2003 Chapman and Hall New York
39. Y. Chen, H.C. Whetstone, A. Youn, P. Nadesan, E.C. Chow, and A.C. Lin et al. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation J Biol Chem 282 2007 526 533
40. Y. Yilmaz Review article: non-alcoholic fatty liver disease and osteoporosis-clinical and molecular crosstalk Aliment Pharmacol Ther 36 2012 345 352
41. S. Pignata, B. Daniele, M.G. Galati, G. Esposito, P. Vallone, and F. Fiore et al. Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma Eur J Gastroenterol Hepatol 9 1997 283 286
42. N.S. Krieger, K.K. Frick, and D.A. Bushinsky Mechanism of acid-induced bone resorption Curr Opin Nephrol Hypertens 13 2004 423 436
43. M.J. Tong, and J. Trieu Hepatitis B inactive carriers: clinical course and outcomes J Dig Dis 14 2013 311 317
44. Y. Yu, R. Gong, Y. Mu, Y. Chen, C. Zhu, and Z. Sun et al. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2 J Immunol 187 2011 4844 4860
45. J.A. Cauley Defining ethnic and racial differences in osteoporosis and fragility fractures Clin Orthop Relat Res 469 2011 1891 1899
46. G.N. Ioannou Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey Ann Intern Med 154 2011 319 328
47. G.M. McQuillan, P.J. Coleman, D. Kruszon-Moran, L.A. Moyer, S.B. Lambert, and H.S. Margolis Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994 Am J Public Health 89 1999 14 18
48. A. Wasley, D. Kruszon-Moran, W. Kuhnert, E.P. Simard, L. Finelli, and G. McQuillan et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination J Infect Dis 202 2010 192 201